Transactions: Healthcare
Filter
Rights offering in Medivir (SE) — SEK 325 million
Rights issue in Oasmia Pharmaceutical (SE) — SEK 123 million
Directed issue of shares in Active Biotech (SE) — SEK 340 million
Acquisition and new share issue in Elekta AB (SE) — Amount not disclosed.
Private placement of equity in BioInvent International AB (SE) — SEK 194 million
Option program in Biacore (SE)
Divestment of Collet Pharma (NO) to Ferd (NO) by Nycomed (DK) — Amount not disclosed.
Public offer for Gambro (SE) by Investor (SE) and EQT (SE) — SEK 39 billion
Divestment of Ambea (SE) by 3i (UK) and other owners to Triton (SE) — EUR 850 million
Directed new share issue in Biotec Pharmacon (NO) — NOK 40 million